Towards a mechanistic understanding of lipodystrophy and seipin functions

Bioscience Reports

Volumn 34, Issue 5, 2014, Pages 583-591

  Wee, Kenneth ^a   Yang, Wulin ^a   Sugii, Shigeki ^a,c   Han, Weiping ^a,b,c  

^a AGENCY FOR SCIENCE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Adipocyte; Lipid droplet; Lipin; Lipolysis; Metabolism; Obesity

Indexed keywords

ANIMALIA;

BSCL2 PROTEIN, HUMAN; BSCL2 PROTEIN, MOUSE; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; LPIN1 PROTEIN, HUMAN; LPIN1 PROTEIN, MOUSE; NUCLEAR PROTEIN; PHOSPHATIDATE PHOSPHATASE; PROTEIN 14 3 3; YWHAB PROTEIN, HUMAN;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL; CONGENITAL GENERALIZED LIPODYSTROPHY; GENETICS; HUMAN; METABOLISM; MOUSE; MUTATION; PATHOLOGY; PROTEIN SECONDARY STRUCTURE;

14-3-3 PROTEINS; ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; GTP-BINDING PROTEIN GAMMA SUBUNITS; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; LIPODYSTROPHY, CONGENITAL GENERALIZED; MICE; MUTATION; NUCLEAR PROTEINS; PHOSPHATIDATE PHOSPHATASE; PROTEIN STRUCTURE, SECONDARY;

EID: 84949117068     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20140114     Document Type: Review

References (77)

1. Garg, A. (2004) Acquired and inherited lipodystrophies. N. Engl. J. Med. 350, 1220-1234 CrossRef PubMed
2. Gomes, K. B., Pardini, V. C. and Fernandes, A. P. (2009) Clinical and molecular aspects of Berardinelli-Seip Congenital Lipodystrophy (BSCL). Clin. Chim. Acta 402, 1-6 CrossRef PubMed
3. Haque, W. A., Shimomura, I., Matsuzawa, Y. and Garg, A. (2002) Serum adiponectin and leptin levels in patients with lipodystrophies. J. Clin. Endocrinol. Metab. 87, 2395-2398 CrossRef PubMed
4. Magre, J., Delepine, M., Khallouf, E., Gedde-Dahl, Jr, T., Van Maldergem, L., Sobel, E., Papp, J., Meier, M., Megarbane, A., Bachy, A. et al. (2001) Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat. Genet. 28, 365-370 CrossRef PubMed
5. Berardinelli, W. (1954) An undiagnosed endocrinometabolic syndrome: report of 2 cases. J. Clin. Endocrinol. Metab. 14, 193-204 CrossRef PubMed
6. Seip, M. (1959) Lipodystrophy and gigantism with associated endocrine manifestation: a new diencephalic syndrome? Acta Paediatr. 48, 555-574 PubMed
7. Simha, V. (2003) Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes. J. Clin. Endocrinol. Metab. 88, 5433-5437 CrossRef PubMed
8. Garg, A., Fleckenstein, J. L., Peshock, R. M. and Grundy, S. M. (1992) Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy. J. Clin. Endocrinol. Metabol. 75, 358-361
9. Maldergem, L. V., Magre, J., Khallouf, T. E., Gedde-Dahl, Jr, T., Delepine, M., Trygstad, O., Seemanova, E., STephenson, T., Albott, C. S., Bonnici, F. et al. (2002) Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy. J. Med. Genet. 39, 722-733 CrossRef PubMed
10. Agarwal, A. K., Arioglu, E., De Almeida, S., Akkoc, N., Taylor, S. I., Bowcock, A. M., Barnes, R. I. and Garg, A. (2002) AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat. Genet. 31, 21-23 CrossRef PubMed
11. Garg, A., Wilson, R., Barnes, R. I., Arioglu, E., Zaidi, Z., Gurakan, F., Kocak, N., O'Rahilly, S., Taylor, S. I., Patel, S. B. and Bowcock, A. M. (1999) A gene for congenital generalized lipodystrophy maps to human chrmosome 9q34. J. Clin. Endocrinol. Metab. 84, 3390-3394 CrossRef PubMed
12. Eberhardt, C., Gray, P. W. and Tjoelker, L. W. (1997) Human lysophosphatidic acid acyltransferase. cDNA cloning, expression, and localization to chromosome 9q34.3. J. Biol. Chem. 272, 20299-20305 CrossRef PubMed
13. Leung, D. W. (2001) The structure and functions of human lysophosphatidic acid acyltransferases. Front. Biosci. 6, D944-D953 CrossRef PubMed
14. Lewin, T. M., Wang, P. and Coleman, R. A. (1999) Analysis of Amino Acid Motifs Diagnostic for the sn -Glycerol-3-phosphate Acyltransferase Reaction. Biochemistry 38, 5764-5771 CrossRef PubMed
15. Magre, J., Delepine, M., Maldergem, L. V., Robert, J.-J., Maassen, J. A., Meier, M., Panz, V. R., Kim, C. A., Tubiana-Rufi, N., Czernichow, P. et al. (2003) Prevalence of mutations in AGPAT2 among human lipodystrophies. Diabetes 52, 1573-1578 CrossRef PubMed
16. -/- mice. Vet. Pathol. 48, 642-654 CrossRef PubMed
17. Cristancho, A. G. and Lazar, M. A. (2011) Forming functional fat: a growing understanding of adipocyte differentiation. Nat. Rev. Mol. Cell Biol. 12, 722-734 CrossRef PubMed
18. Miranda, D. M., Wajchenberg, B. L., Calsolari, M. R., Aguiar, M. J., Silva, J. M., Ribeiro, M. G., Fonseca, C., Amaral, D., Boson, W. L., Resende, B. A. and De Marco, L. (2009) Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli-Seip congenital generalized lipodystrophy syndrome. Clin. Endocrinol. (Oxf.) 71, 512-517 CrossRef PubMed
19. Ebihara, K. (2004) Gene and phenotype analysis of congenital generalized lipodystrophy in Japanese: a novel homozygous nonsense mutation in seipin gene. J. Clin. Endocrinol. Metab. 89, 2360-2364 CrossRef PubMed
20. Patel, H., Hart, P. E., Warner, T. T., Houlston, R. S., Patton, M. A., Jeffery, S. and Crosby, A. H. (2001) The Silver syndrome variant of hereditary spastic paraplegia maps to chromosome 11q12-q14, with evidence for genetic heterogeneity within this subtype. Am. J. Hum. Genet. 69, 209-215 CrossRef PubMed
21. Windpassinger, C., Wagner, K., Petek, E., Fischer, R. and Auer-Grumbach, M. (2003) Refinement of the Silver syndrome locus on chromosome 11q12-q14 in four families and exclusion of eight candidate genes. Hum. Genet. 114, 99-109 CrossRef PubMed
22. Windpassinger, C., Auer-Grumbach, M., Irobi, J., Patel, H., Petek, E., Horl, G., Malli, R., Reed, J. A., Dierick, I., Verpoorten, N. et al. (2004) Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. Nat. Genet. 36, 271-276 CrossRef PubMed
23. Agarwal, A. K. (2003) Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J. Clin. Endocrinol. Metab. 88, 4840-4847 CrossRef PubMed
24. Wei, S., Soh, S. L., Xia, J., Ong, W. Y., Pang, Z. P. and Han, W. (2014) Motor neuropathy-associated mutation impairs Seipin functions in neurotransmission. J. Neurochem. 129, 328-338 CrossRef PubMed
25. Wei, S., Soh, S. L., Qiu, W., Yang, W., Seah, C. J., Guo, J., Ong, W. Y., Pang, Z. P. and Han, W. (2013) Seipin regulates excitatory synaptic transmission in cortical neurons. J. Neurochem. 124, 478-489 CrossRef PubMed
26. Guillen-Navarro, E., Sanchez-Iglesias, S., Domingo-Jimenez, R., Victoria, B., Ruiz-Riquelme, A., Rabano, A., Loidi, L., Beiras, A., Gonzalez-Mendez, B., Ramos, A. et al. (2013) A new seipin-associated neurodegenerative syndrome. J. Med. Genet. 50, 401-409 CrossRef PubMed
27. Kim, C. A., Delepine, M., Boutet, E., El Mourabit, H., Le Lay, S., Meier, M., Nemani, M., Bridel, E., Leite, C. C., Bertola, D. R. et al. (2008) Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J. Clin. Endocrinol. Metab. 93, 1129-1134 CrossRef PubMed
28. Cao, H., Alston, L., Ruschman, J. and Hegele, R. A. (2008) Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia. Lipids Health Dis. 7, 3 CrossRef PubMed
29. Parton, R. G. and Simons, K. (2007) The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol. 8, 185-194 CrossRef PubMed
30. Trigatti, B. L., Anderson, R. G. W. and Gerber, G. E. (1999) Identification of caveolin-1 as a fatty acid binding protein. Biochem. Biophys. Res. Commun. 255, 34-39 CrossRef PubMed
31. Martin, S. and Parton, R. G. (2005) Caveolin, cholesterol, and lipid bodies. Semin. Cell. Dev. Biol. 16, 163-174 CrossRef PubMed
32. Pol, A., Martin, S., Fernandez, M. A., Ferguson, C., Carozzi, A., Luetterforst, R., Enrich, C. and Parton, R. G. (2004) Dynamic and regulated association of caveolin with lipid bodies: modulation of lipid body motility and function by a dominant negative mutant. Mol. Biol. Cell. 15, 99-110 CrossRef PubMed
33. Meshulam, T., Simard, J. R., Wharton, J., Hamilton, J. A. and Pilch, P. F. (2006) Role of caveolin-1 and cholesterol in transmembrane fatty acid movement. Biochemistry 45, 2882-2893 CrossRef PubMed
34. Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C. et al. (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293, 2449-2452 CrossRef PubMed
35. Razani, B., Engelman, J. A., Wang, X. B., Schubert, W., Zhang, X. L., Marks, C. B., Macaluso, F., Russell, R. G., Li, M., Pestell, R. G. et al. (2001) Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276, 38121-38138 CrossRef PubMed
36. Williams, T. M. and Lisanti, M. P. (2005) Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am. J. Physiol. Cell Physiol. 288, C494-C506 CrossRef PubMed
37. Cohen, A. W., Razani, B., Wang, X. B., Combs, T. P., Williams, T. M., Scherer, P. E. and Lisanti, M. P. (2003) Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am. J. Physiol. Cell Physiol. 285, C222-C235 CrossRef PubMed
38. Razani, B., Combs, T. P., Wang, X. B., Frank, P. G., Park, D. S., Russell, R. G., Li, M., Tang, B., Jelicks, L. A., Scherer, P. E. and Lisanti, M. P. (2002) Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J. Biol. Chem. 277, 8635-8647 CrossRef PubMed
39. Rajab, A., Heathcote, K., Joshi, S., Jeffery, S. and Patton, M. (2002) Heterogeneity for congenital generalized lipodystrophy in seventeen patients from Oman. Am. J. Med. Genet. 110, 219-225 CrossRef PubMed
40. Heathcote, K., Rajab, A., Magre, J., Syrris, P., Besti, M., Patton, M., Delepine, M., Lathrop, M., Capeau, J. and Jeffery, S. (2002) Molecular analysis of Berardinelli-Seip congenital lipodystrophy in Oman-evidence for multiple loci. Diabetes 51, 1291-1293 CrossRef PubMed
41. Rajab, A., Straub, V., McCann, L. J., Seelow, D., Varon, R., Barresi, R., Schulze, A., Lucke, B., Lutzkendorf, S., Karbasiyan, M. et al. (2010) Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. PLoS Genet. 6, e1000874 CrossRef PubMed
42. Hayashi, Y. K., Matsuda, C., Ogawa, M., Goto, K., Tominaga, K., Mitsuhashi, S., Park, Y. E., Nonaka, I., Hino-Fukuyo, N., Haginoya, K. et al. (2009) Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. J. Clin. Invest. 119, 2623-2633 CrossRef PubMed
43. Hill, M. M., Bastiani, M., Luetterforst, R., Kirkham, M., Kirkham, A., Nixon, S. J., Walser, P., Abankwa, D., Oorschot, V. M., Martin, S. et al. (2008) PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 132, 113-124 CrossRef PubMed
44. Liu, L. and Pilch, P. F. (2008) A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization. J. Biol. Chem. 283, 4314-4322 CrossRef PubMed
45. Cartwright, B. R. and Goodman, J. M. (2012) Seipin: from human disease to molecular mechanism. J. Lipid Res. 53, 1042-1055 CrossRef PubMed
46. Irobi, J., Van den Bergh, P., Merlini, L., Verellen, C., Van Maldergem, L., Dierick, I., Verpoorten, N., Jordanova, A., Windpassinger, C., De Vriendt, E. et al. (2004) The phenotype of motor neuropathies associated with BSCL2 mutations is broader than Silver syndrome and distal HMN type V. Brain 127, 2124-2130 CrossRef PubMed
47. Lundin, C., Nordstrom, R., Wagner, K., Windpassinger, C., Andersson, H., von Heijne, G. and Nilsson, I. (2006) Membrane topology of the human seipin protein. FEBS Lett. 580, 2281-2284 CrossRef PubMed
48. Yang, W., Thein, S., Guo, X., Xu, F., Venkatesh, B., Sugii, S., Radda, G. K. and Han, W. (2013) Seipin differentially regulates lipogenesis and adipogenesis through a conserved core sequence and an evolutionarily acquired C-terminus. Biochem. J. 452, 37-44 PubMed
49. Huang, H.-H., Chen, T.-H., Hsiao, H.-P., Huang, C.-T., Wang, C.-C., Shiau, Y.-H. and Chao, M.-C. (2010) A taiwanese boy with congenital generalized lipodystrophy caused by homozygous Ile262fs mutation in the BSCL2 gene. The Kaohsiung J. Med. Sci. 26, 615-620 CrossRef
50. Nishiyama, A., Yagi, M., Awano, H., Okizuka, Y., Maeda, T., Yoshida, S., Takeshima, Y. and Matsuo, M. (2009) Two Japanese infants with congenital generalized lipodystrophy due to BSCL2 mutations. Pediatr. Int. 51, 775-779 CrossRef PubMed
51. Sim, M. F., Talukder, M. M., Dennis, R. J., O'Rahilly, S., Edwardson, J. M. and Rochford, J. J. (2013) Analysis of naturally occurring mutations in the human lipodystrophy protein seipin reveals multiple potential pathogenic mechanisms. Diabetologia 56, 2498-2506 CrossRef PubMed
52. Binns, D., Lee, S., Hilton, C. L., Jiang, Q. X. and Goodman, J. M. (2010) Seipin is a discrete homooligomer. Biochemistry 49, 10747-10755 CrossRef PubMed
53. Fei, W., Li, H., Shui, G., Kapterian, T. S., Bielby, C., Du, X., Brown, A. J., Li, P., Wenk, M. R., Liu, P. and Yang, H. (2011) Molecular characterization of seipin and its mutants: implications for seipin in triacylglycerol synthesis. J. Lipid Res. 52, 2136-2147 CrossRef PubMed
54. Payne, V. A., Grimsey, N., Tuthill, A., Virtue, S., Gray, S. L., Dalla Nora, E., Semple, R. K., O'Rahilly, S. and Rochford, J. J. (2008) The human lipodystrophy gene BSCL2/seipin may be essential for normal adipocyte differentiation. Diabetes 57, 2055-2060 CrossRef PubMed
55. Chen, W., Yechoor, V. K., Chang, B. H., Li, M. V., March, K. L. and Chan, L. (2009) The human lipodystrophy gene product Berardinelli-Seip congenital lipodystrophy 2/seipin plays a key role in adipocyte differentiation. Endocrinology 150, 4552-4561 CrossRef PubMed
56. Chen, W., Chang, B., Saha, P., Hartig, S. M., Li, L., Reddy, V. T., Yang, Y., Yechoor, V., Mancini, M. A. and Chan, L. (2012) Berardinelli-Seip congenital lipodystrophy 2/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation. Mol. Cell Biol. 32, 1099-1111 CrossRef PubMed
57. Prieur, X., Dollet, L., Takahashi, M., Nemani, M., Pillot, B., Le May, C., Mounier, C., Takigawa-Imamura, H., Zelenika, D., Matsuda, F. et al. (2013) Thiazolidinediones partially reverse the metabolic disturbances observed in Bscl2/seipin-deficient mice. Diabetologia 56, 1813-1825 CrossRef PubMed
58. Qiu, W., Wee, K., Takeda, K., Lim, X., Sugii, S., Radda, G. K. and Han, W. (2013) Suppression of adipogenesis by pathogenic seipin mutant is associated with inflammatory response. PLoS ONE 8, e57874 CrossRef PubMed
59. Yang, W., Thein, S., Wang, X., Bi, X., Ericksen, R. E., Xu, F. and Han, W. (2014) BSCL2/seipin regulates adipogenesis through actin cytoskeleton remodelling. Hum. Mol. Genet. 23, 502-513 CrossRef PubMed
60. Dollet, L., Magre, J., Cariou, B. and Prieur, X. (2014) Function of seipin: new insights from Bscl2/seipin knockout mouse models. Biochimie 96, 166-172 CrossRef PubMed
61. Ito, D. and Suzuki, N. (2007) Molecular pathogenesis of seipin/BSCL2-related motor neuron diseases. Ann. Neurol. 61, 237-250 CrossRef PubMed
62. Guo, J., Qiu, W., Soh, S. L., Wei, S., Radda, G. K., Ong, W. Y., Pang, Z. P. and Han, W. (2013) Motor neuron degeneration in a mouse model of seipinopathy. Cell Death Dis. 4, e535 CrossRef PubMed
63. Fei, W., Shui, G., Gaeta, B., Du, X., Kuerschner, L., Li, P., Brown, A. J., Wenk, M. R., Parton, R. G. and Yang, H. (2008) Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast. J. Cell Biol. 180, 473-482 CrossRef PubMed
64. Wolinski, H., Kolb, D., Hermann, S., Koning, R. I. and Kohlwein, S. D. (2011) A role for seipin in lipid droplet dynamics and inheritance in yeast. J. Cell Sci. 124, 3894-3904 CrossRef PubMed
65. Clement, S., Fauvelle, C., Branche, E., Kaddai, V., Conzelmann, S., Boldanova, T., Bartosch, B., Minehira, K. and Negro, F. (2013) Role of seipin in lipid droplet morphology and hepatitis C virus life cycle. J. Gen. Virol. 94, 2208-2214 CrossRef PubMed
66. Sim, M. F., Dennis, R. J., Aubry, E. M., Ramanathan, N., Sembongi, H., Saudek, V., Ito, D., O'Rahilly, S., Siniossoglou, S. and Rochford, J. J. (2012) The human lipodystrophy protein seipin is an ER membrane adaptor for the adipogenic PA phosphatase lipin 1. Mol. Metab. 2, 38-46 CrossRef PubMed
67. Koh, Y. K., Lee, M. Y., Kim, J. W., Kim, M., Moon, J. S., Lee, Y. J., Ahn, Y. H. and Kim, K. S. (2008) Lipin1 is a key factor for the maturation and maintenance of adipocytes in the regulatory network with CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma 2. J. Biol. Chem. 283, 34896-34906 CrossRef PubMed
68. Cui, X., Wang, Y., Meng, L., Fei, W., Deng, J., Xu, G., Peng, X., Ju, S., Zhang, L., Liu, G. et al. (2012) Overexpression of a short human seipin/BSCL2 isoform in mouse adipose tissue results in mild lipodystrophy. Am. J. Physiol. Endocrinol. Metab. 302, E705-E713 CrossRef PubMed
69. (2)(+)-ATPase SERCA. Cell Metab. 19, 861-871 CrossRef PubMed
70. Mynarcik, D. C., McNurlan, M. A., Steigbigel, R. T., Fuhrer, J. and Gelato, M. C. (2000) Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy. J. Acquir. Immune Defic. Syndr. 25, 312-321 CrossRef PubMed
71. Torrelo, A., Patel, S., Colmenero, I., Gurbindo, D., Lendinez, F., Hernandez, A., Lopez-Robledillo, J. C., Dadban, A., Requena, L. and Paller, A. S. (2010) Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome. J. Am. Acad. Dermatol. 62, 489-495 CrossRef PubMed
72. Herrero, L., Shapiro, H., Nayer, A., Lee, J. and Shoelson, S. E. (2010) Inflammation and adipose tissue macrophages in lipodystrophic mice. Proc. Natl. Acad. Sci. U. S. A. 107, 240-245 CrossRef PubMed
73. Senn, J. J., Klover, P. J., Nowak, I. A. and Mooney, R. A. (2002) Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51, 3391-3399 CrossRef PubMed
74. Rotter, V., Nagaev, I. and Smith, U. (2003) Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J. Biol. Chem. 278, 45777-45784 CrossRef PubMed
75. Kawasaki, N., Asada, R., Saito, A., Kanemoto, S. and Imaizumi, K. (2012) Obesity-induced endoplasmic reticulum stress causes chronic inflammation in adipose tissue. Sci. Rep. 2, 799 CrossRef PubMed
76. Kim, H. B., Kumar, A., Wang, L., Liu, G. H., Keller, S. R., Lawrence, Jr, J. C., Finck, B. N. and Harris, T. E. (2010) Lipin 1 represses NFATc4 transcriptional activity in adipocytes to inhibit secretion of inflammatory factors. Mol. Cell Biol. 30, 3126-3139 CrossRef PubMed
77. Takahashi, N., Yoshizaki, T., Hiranaka, N., Suzuki, T., Yui, T., Akanuma, M., Oka, K., Kanazawa, K., Yoshida, M., Naito, S. et al. (2011) Suppression of lipin-1 expression increases monocyte chemoattractant protein-1 expression in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 415, 200-205 CrossRef PubMed